Italy drafts extra Euros8bn for healthcare in 2005
This article was originally published in Clinica
Italian health minister Girolamo Sirchia yesterday presented a draft of the 2005 budget of the national healthcare system (SSN), proposing a 9.9% increase to Euros89bn ($110bn), from Euros81bn in the current year.
You may also be interested in...
Mylan first announced plans to develop a biosimilar of the Botox cosmetic and therapeutic brands back in 2018 through an alliance with Revance Therapeutics. More than two years later, a verdict has been reached by the company.
Separate concerns raised by the EMA over bioequivalence studies have led Mylan and Accord to withdraw generic applications, including the former’s generic version of Gilenya for the treatment of multiple sclerosis.
New York's Avista Capital Partners has taken a 50% stake in Belgian consumer health player Vision Healthcare, which has its sights set on the US market.